Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model.

Por Le Conte, P, Le Gallou, F, Potel, G, Struillou, L, Baron, D, Drugeon, H B
Publicado em 1994

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

Por Dieci, M. V., Mathieu, M. C., Guarneri, V., Conte, P., Delaloge, S., Andre, F., Goubar, A.
Publicado no Ann Oncol (2015)

Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy

Por Gennari, A, Bruzzi, P, Orlandini, C, Salvadori, B, Donati, S, Landucci, E, Guarneri, V, Rondini, M, Ricci, S, Conte, P
Publicado em 2004

In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model.

Por Bugnon, D, Potel, G, Xiong, Y Q, Caillon, J, Kergueris, M F, Le Conte, P, Baron, D, Drugeon, H
Publicado em 1996

Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC)

Por Baldini, E, Ardizzoni, A, Prochilo, T, Cafferata, M A, Boni, L, Tibaldi, C, Neumaier, C, Conte, P F, Rosso, R
Publicado em 2001

Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based c...

Por Buda, A, Floriani, I, Rossi, R, Colombo, N, Torri, V, Conte, P F, Fossati, R, Ravaioli, A, Mangioni, C
Publicado em 2004

Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomo...

Por Xiong, Y Q, Potel, G, Caillon, J, Stephant, G, Jehl, F, Bugnon, D, Le Conte, P, Baron, D, Drugeon, H
Publicado em 1995

Gastric cancer in elderly: clinico-pathological features and surgical treatment

Por Guida, F, Antonino, A, Conte, P, Formisano, G, Esposito, D, Bencivenga, M, Aprea, G, Amato, B, Avallone, U, Persico, G
Publicado no BMC Geriatr (2009)

Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis.

Por Potel, G, Caillon, J, Le Gallou, F, Bugnon, D, Le Conte, P, Raza, J, Lepage, J Y, Baron, D, Drugeon, H
Publicado em 1992

In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.

Por Juvin, M E, Potel, G, Caillon, J, Xiong, Y Q, Bugnon, D, Le Conte, P, Baron, D I, Drugeon, H B
Publicado em 1994

Phase II study of lonidamine in metastatic breast cancer.

Por Pronzato, P., Amoroso, D., Bertelli, G., Conte, P. F., Cusimano, M. P., Ciottoli, G. B., Gulisano, M., Lionetto, R., Rosso, R.
Publicado em 1989

Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I–II study

Por Tibaldi, C, Prochilo, T, Russo, F, Pennucci, M C, Del Freo, A, Innocenti, F, Fabbri, A, Falcone, A, Conte, P F, Baldini, E
Publicado em 2006

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

Por Tubiana-Mathieu, N, Bougnoux, P, Becquart, D, Chan, A, Conte, P-F, Majois, F, Espie, M, Morand, M, Vaissiere, N, Villanova, G
Publicado em 2009

Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy

Por Bengala, C, Bettelli, S, Bertolini, F, Sartori, G, Fontana, A, Malavasi, N, Depenni, R, Zironi, S, Del Giovane, C, Luppi, G, Conte, P F
Publicado em 2010

Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.

Por Potel, G, Caillon, J, Fantin, B, Raza, J, Le Gallou, F, Lepage, J Y, Le Conte, P, Bugnon, D, Baron, D, Drugeon, H
Publicado em 1991

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

Por Dieci, M. V., Criscitiello, C., Goubar, A., Viale, G., Conte, P., Guarneri, V., Ficarra, G., Mathieu, M. C., Delaloge, S., Curigliano, G., Andre, F.
Publicado em 2014

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

Por Dieci, M. V., Criscitiello, C., Goubar, A., Viale, G., Conte, P., Guarneri, V., Ficarra, G., Mathieu, M. C., Delaloge, S., Curigliano, G., Andre, F.
Publicado no Ann Oncol (2015)

Mitomycin-ifosfamide-cisplatinum (MIP) vs MIP-interferon vs cisplatinum-carboplatin in metastatic non-small-cell lung cancer: a FONICAP randomised phase II study. Italian Lung Canc...

Por Ardizzoni, A., Addamo, G. F., Baldini, E., Borghini, U., Portalone, L., De Marinis, F., Lionetto, R., Conte, P. F., Bruzzi, P., Pennucci, M. C.
Publicado em 1995

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

Por Bengala, C, Bertolini, F, Malavasi, N, Boni, C, Aitini, E, Dealis, C, Zironi, S, Depenni, R, Fontana, A, Del Giovane, C, Luppi, G, Conte, P
Publicado em 2010

Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety

Por Baldini, E, Prochilo, T, Salvadori, B, Bolognesi, A, Aldrighetti, D, Venturini, M, Rosso, R, Carnino, F, Gallo, L, Giannessi, P, Conte, P F, Orlandini, C, Bruzzi, P
Publicado em 2004